The Sealy Institute for Vaccine Sciences
December 2001 the Sealy Center for Vaccine Development (SCVD) was
established at UTMB. In January 2018, vaccine research and development
has expanded at UTMB with the inauguration of the Sealy Institute for
Vaccine Sciences (SIVS). The SIVS will help support and guide the development of prophylactic and therapeutic vaccines at UTMB.
The mission of the Sealy Institute for Vaccine Sciences (SIVS) is to improve human health by:
- Conducting research focused on the development and use of vaccines
- Developing public policy and education programs to foster vaccine acceptance
- Training investigators in the field of vaccine research
With 76 UTMB faculty members from twelve School of Medicine departments, the
institute incorporates the expertise of more than 100 cutting-edge
research programs currently at the UTMB. The faculty and staff of the
SIVS strive to create, perfect and promote the most effective and safest
disease prevention strategies. In this endeavor, the institute carries
on the proud tradition of medical research and discovery that has been a
hallmark of UTMB since its beginning.